CA2327393C - Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires - Google Patents

Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires Download PDF

Info

Publication number
CA2327393C
CA2327393C CA002327393A CA2327393A CA2327393C CA 2327393 C CA2327393 C CA 2327393C CA 002327393 A CA002327393 A CA 002327393A CA 2327393 A CA2327393 A CA 2327393A CA 2327393 C CA2327393 C CA 2327393C
Authority
CA
Canada
Prior art keywords
ala
solution
solution according
ester
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002327393A
Other languages
English (en)
French (fr)
Other versions
CA2327393A1 (fr
Inventor
Alexandre Marti
Norbert Lange
Matthieu Zellweger
Georges Wagnieres
Hubert Van Den Bergh
Patrice Jichlinski
Pavel Kucera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
École Polytechnique Fédérale de Lausanne
University of Lausanne
Original Assignee
École Polytechnique Fédérale de Lausanne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by École Polytechnique Fédérale de Lausanne filed Critical École Polytechnique Fédérale de Lausanne
Publication of CA2327393A1 publication Critical patent/CA2327393A1/fr
Application granted granted Critical
Publication of CA2327393C publication Critical patent/CA2327393C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
CA002327393A 1998-04-22 1999-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires Expired - Lifetime CA2327393C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9805425A FR2777782B1 (fr) 1998-04-22 1998-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
FR98/05425 1998-04-22
PCT/CH1999/000163 WO1999053962A1 (fr) 1998-04-22 1999-04-22 Solution pour le diagnostic ou le traitement de lesions tissulaires

Publications (2)

Publication Number Publication Date
CA2327393A1 CA2327393A1 (fr) 1999-10-28
CA2327393C true CA2327393C (fr) 2006-04-04

Family

ID=9525850

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002327393A Expired - Lifetime CA2327393C (fr) 1998-04-22 1999-04-22 Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires

Country Status (9)

Country Link
US (1) US7348361B2 (cg-RX-API-DMAC7.html)
EP (1) EP1073472B1 (cg-RX-API-DMAC7.html)
JP (2) JP4630395B2 (cg-RX-API-DMAC7.html)
AT (1) ATE228018T1 (cg-RX-API-DMAC7.html)
CA (1) CA2327393C (cg-RX-API-DMAC7.html)
DE (1) DE69904033T2 (cg-RX-API-DMAC7.html)
ES (1) ES2188146T3 (cg-RX-API-DMAC7.html)
FR (1) FR2777782B1 (cg-RX-API-DMAC7.html)
WO (1) WO1999053962A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US6570001B1 (en) * 1997-06-20 2003-05-27 Institut Pasteur Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
RU2218570C2 (ru) * 2001-11-01 2003-12-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Способ флюоресцентной диагностики новообразований
EP1312353A1 (en) * 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
US20090227997A1 (en) * 2006-01-19 2009-09-10 The Regents Of The University Of Michigan System and method for photoacoustic imaging and monitoring of laser therapy
US20080123083A1 (en) * 2006-11-29 2008-05-29 The Regents Of The University Of Michigan System and Method for Photoacoustic Guided Diffuse Optical Imaging
DK2272538T3 (da) * 2008-04-22 2020-10-26 Sbi Pharmaceuticals Co Ltd Fremgangsmåde til påvisning af blærecancer
TWI426133B (zh) * 2008-05-30 2014-02-11 Jfe Steel Corp Production method of pig iron
KR101322259B1 (ko) 2008-10-27 2013-10-28 에스비아이 파마 가부시키가이샤 5-아미노레불린산 혹은 그의 유도체, 또는 그들 염을 유효성분으로 하는 성인병의 예방·개선제
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
JP2011001307A (ja) * 2009-06-19 2011-01-06 Sbi Alapromo Co Ltd ５−アミノレブリン酸による子宮頸がん判定・治療システム
JP2013521251A (ja) * 2010-03-01 2013-06-10 フォトキュア エイエスエイ 美容組成物
NZ603465A (en) 2010-05-19 2013-10-25 Sbi Pharmaceuticals Co Ltd Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
US20130211215A1 (en) * 2010-06-23 2013-08-15 Photocure Asa Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
EP2727603B1 (en) 2011-07-01 2023-09-06 SBI Pharmaceuticals Co., Ltd. Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid
JP6052736B2 (ja) 2011-08-12 2016-12-27 Ｓｂｉファーマ株式会社 敗血症の予防剤及び／又は治療剤
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
JP6546164B2 (ja) * 2014-06-11 2019-07-17 日本板硝子株式会社 複層ガラスユニットおよび複層ガラスユニット用ガラス板
US9733187B2 (en) 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CA3024996A1 (en) * 2016-06-08 2017-12-14 Cf Genome, Llc A chemical composition to stabilize extracellular vesicles in a blood sample and method of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
DE122006000051I1 (de) * 1995-03-10 2007-01-04 Photocure Asa Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid

Also Published As

Publication number Publication date
WO1999053962A1 (fr) 1999-10-28
ES2188146T3 (es) 2003-06-16
JP2002512205A (ja) 2002-04-23
JP4630395B2 (ja) 2011-02-09
US7348361B2 (en) 2008-03-25
EP1073472B1 (fr) 2002-11-20
ATE228018T1 (de) 2002-12-15
FR2777782B1 (fr) 2001-05-18
JP2010163445A (ja) 2010-07-29
EP1073472A1 (fr) 2001-02-07
US20030158258A1 (en) 2003-08-21
DE69904033T2 (de) 2003-10-09
FR2777782A1 (fr) 1999-10-29
DE69904033D1 (de) 2003-01-02
CA2327393A1 (fr) 1999-10-28

Similar Documents

Publication Publication Date Title
EP1073472B1 (fr) Solution d'un ester de l' ala pour le diagnostic ou le traitement de lesions tissulaires
Peng et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate
Ashur et al. Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin
CN101056626B (zh) 利用5-氨基乙酰丙酸衍生物治疗痤疮
Fingar et al. The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy
US20030176411A1 (en) Photodynamic therapy for pre-melanomas
Moy et al. Photodynamic therapy for photodamage, actinic keratosis, and acne in the cosmetic practice
JP2002512205A5 (cg-RX-API-DMAC7.html)
Krammer et al. In-vitro investigation of ALA-induced protopoyphyrin IX
Donnelly et al. Derivatives of 5-aminolevulinic acid for photodynamic therapy
Marcus et al. Photodynamic therapy systems and applications
JP2017503785A (ja) 座瘡のパルス光力学的処置
Sharma et al. Mechanisms of photodynamic therapy
Abels et al. Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene
Foged et al. Thermo‐mechanical fractional injury enhances skin surface‐and epidermis‐protoporphyrin IX fluorescence: comparison of 5‐aminolevulinic acid in cream and gel vehicles
Schacht et al. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application
EP2882432B1 (en) Method for the treatment of acne
Gottfried et al. Vascular damage during PDT as monitored in the chick chorioallantoic membrane
Alexeree Photodynamic therapy based on curcumin-mediated nanomedicines for wound healing
JP2006523119A (ja) 長期的な腫瘍停留を示す光増感剤を用いた多回投与プロトコールによる光線力学療法の改善された効果及び安全性
Bagnato et al. Photodynamic reactions: cancer and microbiological control
González et al. The phototoxicity of photodynamic therapy may be suppressed or enhanced by modulation of the cutaneous vasculature
Colin et al. Thérapie photodynamique et cancer de la prostate
US20030083324A1 (en) Photosensitizing ointment
JP2006514072A (ja) 光線療法における適用のための、並びに皮膚及び／又は関節疾患の処置のためのポルフィリン合成の物質の使用

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190423